Want to join the conversation?
Maker of private-label OTC drugs $PRGO's unallocated expenses were $151MM for the six months ended Dec. 31, 2015 vs. $49.6MM for the six months ended Dec. 27, 2014. The $101.4MM increase was mainly due to $86.9MM in fees incurred in the company's defense against $MYL's unsolicited tender offer and $7.5MM in corporate restructuring charges.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.